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wi~ich provided protection against the effects of ischemia and raperfusion in a dose- 
dependent fashion. In addition, L-arginine eardioprotection was mediated by the activa- 
tion of guanyiate cyclaee leading to increased cGMP levels in human heart cells. The 
final effector of NO/cGMP may be the opening of KAT P channels. 
5:00 p.m. 
411-5 L-Arginine for  Partial Reeynchronization of Abnormal  
Peripheral Vascular Reactivity in Heart Failure: A 
Prospective Randomized Double-Blind Study 
Moi~ammed Yousufuddirl, Mohamed Amrani, Waqar Shamim, Faisal AI-Nasser, Fouad 
Amin, Nicholas R. Banner, Andrew J S. Coats, Nationa/Heart and Lung/nstitute, 
London, United Kingdom. 
We investigated the effects of oral I-arginine (ARG) supplement on brachial artery (BA) 
reactivity in patient with CHF. Methods: Fiffy-men (59±10 yr.) with stable CHF of NYHA 
grade I-III and ejection fraction <40% were randomized to oral ARG or matching placebo 
for 1-week. Twenty-healthy men (57±9yr) with no clinical evidence of disease served as 
parallel controls for baseline comparison. BA reactivity was measured as a) flow-medi- 
ated dilation (FMD) in response to hyperemia induced by 5-min of distal forearm occlu- 
sion by blood pressure cuff, b) exercise-induced constriction (EIC) immediately after 
treadmill exemise, and c) resting, hyperemic and post-exeroise BA blood flow by high- 
resolution ultrasound technique using 8-11 MHz vascular probe connected to SONO 
5500 (Agilant Tech, USA). FMD and EIC were measured as % change in diameter of the 
BA after increased flow and exemise respectively. Exercise was performed with modified 
Bruce protocol and peak oxygen consumption (VO2) was measured (AMIS 2000, Den- 
mark). Exhaled nitric oxide (NO) was measured by a chemiluminescence analyzer. 
Investigations were performed after overnight fast under identical condition. Inferential 
statistics were restricted to CHF patients. Results: ARG and placebo patient-groups and 
controls were similar in demographics. Baseline characteristics were comparable 
between ARG and placebo groups in patients. Controls and patients differ in their BA 
reactivity and exercise capacity with former showing higher FMD and VO 2 but lower EIC 
(all P<0.0001). At one-wk FMD (2.24t-0.89 to2.6±1.1 Vs 2.3t0.32 to 2.3+1.07%;P=0.02) 
has increased while EIC (7.2±4.0 to 5.3±2.8 vs 5.9±3.2 to 5.8+3.1%;p=0.02) decreased 
with ARG supplementation compared to placebo in patients. Exhaled NO was increased, 
independent of changes in FMD or EIC in ARG arm compared to placebo (7.6±2.8 to 
9.4+3.4; vs 8.9-~2.5 to 9.4±3.4 parts per billion; P=0.01). Patients, who received ARG 
demonstrated a strong trend toward increase in exercise interval, VO2, and hyperamic 
blood flow compared to placebo group. Conclusion: ARG, via an increase in NO bioavial- 
ability, partially resynchronizes brachial artery reactivity towards normal in patients with 
CHF. 
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An Institutional Discharge Medication Program 
Reduces Future Cardiovascular Readmiselons and 
Mortality: An Analysis of 43,841 Patients With Coronary 
Artery Disease 
Robert R. Pearson. Benjamin D. Home, Chloe A. Allen Maycock, Donald L. Lappe', 
Susan Krelick-Goldberg, Tami L. Bair, Janette A. Orton, Diane S. Wallace, Haeli 
Hanseen, Dale G. Renlund, Joseph B. Muhlestein, LDS Hospital Salt Lake Ci~ Utah. 
Background: Patients (pts) admitted with a diagnosis of coronary artery disease (CAD) 
carry a significant risk of re-hospitalization or death during the year after discharge. We 
have shown that successful implementation of a multi-faceted ischarge medication pro- 
gram (DMP) increases the likelihood of CAD pts being discharged on appropriate medi. 
cal therapy (ASNAntiplatelet and a statin for all; Beta-Blockers post-MI). We 
hypothesized that this DMP would result in reduced cardiovascular eadmissions and 
mortality. 
Methods: We analyzed 43,841 pts discharged after a CAD-related hospitalization from 
10 hospitals within an integrated health care system. Implementation of the DMP was ini- 
tiated in 1/1999 and increased overall medication use from 65% to 95%. We compared 
one year cardiovascular eadmission or death rates of pts discharged between 1/1996- 
12/1998 (n=25,185) (pre-DMP) to pts discharged between 1/1999-6/2000 (n=18,656) 
(post-DMP). 
Results: Average pt age was 64±15 years; 62% were male; demographics did not differ 
between pre- and post-DMP groups. After controlling for age and gender in Cox regres- 
sion, post-DMP one-year re-admission rates were reduced from 20.4% to 17.7% (hazard 
ratio lHR]=0.86, p<0.001) and one-year mortality was reduced from 4.5% to 3.5% 
(HR--0.79, p<0.001). 
Conclusions: The successful implementation of an institutional cardiac DMP can signifi- 
cantly lower the rate at which pts with CAD are rsadmitted for cardiac complications and 
also will lower their mortality rates. 
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849-2 Quality of Care of Patients Admitted With Congeative 
Heart Failure: Influence of Physician Specialty end 
Hospital Type 
Jay K. Amin. Michael J. Lim, Yassar Almanaseer, Chih-Wen Pal, Gerdann Finnegen, Kim 
A. Eagle, Rajendre H. Mehta, University of Michigan, Ann Arbor, Michigan, Michigan 
Peer Review Organization, Plymouth, Michigan. 
Background: Congestive heart failure (CHF) is a common admission diagnosis in eld- 
edy patients (pts) in the United States. Increased resource utilization by CHF pts has 
generated great interest in improving quality of care for these pts. The impact of physi- 
cian specialty and hospital type on the quality of care has not been well studied. 
Methods: We evaluated 5871 Medicare beneficiadas admitted to 31 acute care hospitals 
in Southeast Michigan with CHF (1/98-12/98). Patients were identified retrospectively 
using ICD-9 codes for CHF. Indicators were evaluated with respect to physician specialty 
(cardiologist vs. non-cardiologist) and hospital type (teaching, n=17 vs. non-taaching, 
n=14). 
Results: Indicators are shown (Table). Patients treated by cardiologists had shorter 
length of stay (LOS, 5.5 vs. 6.0 days, p<.001) and similar 1-year mortality rates (37.9% 
vs. 35%, p=.06) compared to non-cardiologists. Patients treated in teaching hospitals 
had shorter LOS (5.6 vs. 6.1 days, p<.001) and lower 1-year mortality rates (34.7% vs. 
37.4%, p=.04). 
Conclusion: Quality of care for CHF pts tends to be less optimal in those treated by non- 
cardiologists and at non-teaching hospitals despite similar or higher mortality rates. This 
data supports the need for further educating non-cardiologists in the management of eld- 
erly pts admitted with CHF. In addition, it suggests that systemization of processes at 
non-teaching hospitals may improve the quality of care for CHF pts, thus leading to petter 
long-term outcomes. 
Quality Indicators Teaching Non- PValue Cardiologist, Non- PValue 
Hospital, teaching n=1297 cardiologist, 
n=3350 Hospital, n=3599 
n=2521 
Discharge ACE-inhibitor/ARB 81.6 73 <0.001 79.6 76.5 0.24 
(%) 
LVEF documented (%) 70.5 64.6 <0.001 65.3 68.3 0.05 
Discharge smoking cessation 24.0 34.5 0.08 28.1 27.9 0.98 
counseling (%) 
Discharge written instructions 97.0 97.3 0.75 97.8 97 0.43 
(%) 
Weights measured, >50% 68.4 61.6 0.006 77.7 62.6 <0.001 
hospital days (%) 
Discharge warfarin in CHF pts 48.7 41.7 0.16 56.5 39.1 <0.001 
with atrial fibrillation (%) 
9:00 a.m. 
849-3 Regional Differences in Quality of Care for Heart 
Failure: The Role of Patient, Physician, and Hospltsl 
Characteristics 
Edward P. Havranek, Pare Wolfe, Frededck A. Masoudi, Hadan M. Krumholz, Saif S. 
Rathore, Beth Stevens, Diana L. Ordin, Colorado Foundation for Medical Care, Aurora, 
Colorado. 
Background: Quality of care for eldedy heart failure patients varies across the United 
States, but the extent to which patient, provider and hospital charecteristics contribute to 
this vadation is unknown. Methods: We used data from the National Heart Failure 
project, a Center for Medicare and Medicaid Services quality initiative that studied 37,500 
Medicare patients hospitalized with heart failure, to evaluate the extent to which patient, 
physician and hospital characteristics explain regional vadation in heart failure treatment. 
Small area variation for two quality indicators (QI)- documentation of ejection fraction 
(EF) and appropriate prescription of angiotansin converting enzyme inhibitor (ACEI)- was 
assessed by estimating the Ol rates by Hospitat Referral Regions (HRRs) in the United 
States using a non-linear mixed-effects model To identify variables associated with per- 
formance on the quality indicators by census divisions we used the method of general- 
ized estimating equations for a logistic model entenng HRR as a random effect. We 
compared the distribution of the predictors across regions using a chi-squara test for 
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independence. Results: Smoothed rates of documentation of EF varied from 35-85% and 
of ACEI prescdption from 65-87% by HRR. Among 32,882 patients eligible for the EF QI, 
advanced age (OR 0.64, 95% CI 0.61-0.69), female gender (OR 0.87, 95% CI 0.82- 
0.92), low income (OR 0.77, 95% CI 0.73-0,82), hospital with invasive cardiac capabili- 
ties (OR 1.58, 95% CI 1.42-1.74), hospital with a medical school affiliation (OR 1.45, 95% 
CI 1.32-1.59), rural location (OR 0.50, 95% CI 0.45-0.56) and cardiologist as attending 
physician (OR 1.38, 95% CI 1.26-1.52) were independently associated with documenta- 
tion of El=. Among 9,368 patients eligible for the ACEI QI, female gender (OR 0.81, 95% 
CI 0.73-0.89), higher serum creatinine (OR 0.54, 95% CI 0.50-0.57), black race (OR 
1.34, 95% CI 1.13-1.59) and hospitalization at a teaching facility (OR 1.36, 95% CI 1.17- 
1.59) were independently associated with ACEI prescription. Conclusions: Patient, pro- 
vider and hospital characteristics contribute to but do not fully explain variation in quality 
of care for elderly heart failure patients. 
9:15 a.m. 
849-4 Effectiveness of Quality Improvement Initiative 
(Guidelines Applied to Practice[GAP] Project) in 
Improving the Care of Medicare Patlente and Women 
With Acute Myocardial Infarction 
Raiendra H. Mehta, Cecelia K. Montoye, Meg Gallogly, Patricia Baker, Angela Blount, 
Staven Borzak, Eva Kline-Rogers, Thomas LaLonde, Michele Orza, Robert Parrish, 
Stuart Winston, Arthur A. Riba, Kim A. Eagle, On Behalf of GAP Investigators, University 
of Michigan Health System, Ann Arbor, Michigan. 
Background: Quality of care of patients with acute myocardial infarction (AMI) has been 
shown to be particularly suboptimal in the Medicare population and in females. Hence, 
improving care in this cohort prone to be deprived of key indicators for AMI care is of 
intense interest. 
Methods: To assess if a quality improvement initiative is effective in improving adher- 
ence to evidenca-based therapies in Medicare beneficiaries and women, we evaluated 
patients from the Guidelines Applied to Practice (GAP) project sponsored by the Ameri- 
can College of Cardiology. The GAP design consisted of baseline measurement, imple- 
mentation of improvement strategies (including among other components the use of tools 
designed to facilitate the adherence to key quality indicators); remeasurement; and com- 
parison of pre- and post samples. A random sample of Medicare and non-Medicare 
patients admitted for the treatment of confirmed AMI to 10 acute care hospitals in South- 
east Michigan at baseline (n=735) and following intervention (n=914) constituted the 
study population. 
Reeults: See table. # =test indicators, * = p < 0.05, pre =pre-intervention, post =post- 
intervention. 
Con¢luelons: The quality of care for Medicare beneficiaries and women with AMI was 
less optimal than for non-Medicare patients and men in the pre-GAP phase. A greater 
improvement was observed for most quality indicators for Medicare patients and women 
as oppose to non-Medicare patients and men, thereby ameliorating the 'GAP' in the care 
among these subgroups. 
Quality Indicators Non- Medicare Men Women 
Medicare 
Pre Post Pre Post Pre Post Pre Post 
N (%) 220 251 515 663 409 505 326 409 
(29.9) (27.5) (70.1) (72.5) (55.6) (55.3) (44.4) (44.7) 
Early aspirin % 90.6 88.0 76.6 87.1" 85.7 87.6 75.5 87.2* 
Early betablockers % 70.1 75.8 62.5 73.3* 71.4 73.4 55.0 75.5* 
Late aspirin % 86.8 92.8 82.0 91.7* 84.4 91.8* 83.0 92.6* 
Latebetablockers% 90.7 93.4 87.3 92.9 90.1 92.5 85.7 93.9* 
Discharge ACEinhibitors% 79.4 90.5 80.8 84.7 79.8 91.2* 80.0 78.9 
Smoking cessation % 70.2 79.7 27.7 50.4* 56.3 63.6 44.7 68.8* 
Early ACE inhibitors %# 35.0 42.2 33.7 43.7* 35.5 43.2 32.2 43.3* 
Diet counseling %# 75.5 80.0 61.7 65.5 70.8 73.2 60.3 65.7 
LDLassessment %# 72.2 75.8 58.4 67.1 66.2 67.2 61.1 72.3 
Cholasterol management %# 70.5 86.4 66.2 69.9 64.3 76.7 73.8 73.0 
9:30 a.m. 
849-5 Strategies to Improve Guideline Adherence: A 
Randomized Clinical Trial 
Maria N. Ansari, Michael G. Shlipak, Paul A. Heidenreich, Barrv M. Massie. San 
Francisco VA Medical Center, San Francisco, California, UCSF, San Francisco, 
California. 
Background Clinical practice guidelines are designed to translate medical resaarch and 
expert opinion into recommendations for everyday practice; however their ability to affect 
clinician behavior has been limited. Objective To evaluate interventions for implementing 
a new practice guideline, which advocates beta-blockers (BBs) for patients (pts) with 
heart failure (HI=). Design and setting This study was a clinical trial that randomized pro- 
viders at the San Francisco VA Medical Center to one of 3 groups on 2/1/00: 1) Control: 
provider education (n= 25 providers, 61 pts); 2'~ Alert: computerized reminders to provid- 
ers and letters advocating BBs to pts (n=24 providers, 64 pts); and 3) Nurse Manaoe- 
ment: supervised nurse practitioner to initiate and titrate BBs with provider consent (n=25 
providers, 54 pts). The primary outcome was the proportion of pts identified as appropri- 
ate BB candidates who were initiated and maintained on BBs after 1 year of intervention 
or at the study endpoint on 4/16/01. Secondary outcomes included hospitalizations and 
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adverse events. Participant,= Inclusion criteria for pts were an ICD-9 HF diagnosis, 
EF_<45% and clinical evidence of HF. Exclusions included prior intolerance to BBs, BB 
use at target dose, lack of primary care at the VA, HR<60, SBP<90, severe COPD, 
asthma, diabetes with hypoglycamic events, and terminal comorbidities. Results Char- 
actedstics of providers (specialty, training level) and pts (age, EF, HF etiology, ocmorbidi- 
ties) were similar in the 3 intervention arms. Providers assigned to the Nurse 
Management arm initiated and maintained BBs in 61% of candidate pts compared with 
29% (p<.01) in the Control group and 12% (p<.001) in the Alert group. The Nurse Man- 
agement group also had the highest proportion of pts reaching target BB doses (43% vs. 
1.5% and 10%, p<0.001 for both) compared to the Alert and Control arms. There was no 
difference in adverse events (ER visits, hospitalizations, or deaths) during follow-up. 
Conclusions The use of a nurse manager was a successful and safe approach for 
implementing a BB guideline in HF pts. The use of provider education, clinical reminders, 
and patient education were of limited benefit in this setting. 
9:45 a.m. 
849-6 Quality Improvement Over Time: Hospital 
Characteristics Associated With Increased Usage of 
Beta-Blockers After Myocardial Infarction 
Jennifer A. Mattera, Jeph Herrin, Elizabeth H. Bradley, Eric S. Holmboe, Paul Frederick, 
Hal V. Barren, Katherine A. Littrell, Nathan R. Every, Harlan M. Krumholz, Yale 
Universi~ New Haven, ConnecticuL 
Background: National organizations have focused on improving quality of care by 
increasing the use of beta-blockers (BB) at hospital discharge after acute myocardial inf- 
arction (AMI). Little is known about the factors associated with hospital performance 
improvement. Our objective was to determine the hospital characteristics independently 
associated with increasing the use of BB over time. 
Methods: We examined data on 325,510 discharges at 665 hospitals in the United States 
collected for the National Registry of Myocardial Infarction from 1996 to 1999. Using 
logistic hierarchical modeling techniques we examined the hospital-level characteristics 
associated with increasing use of BB after AMI over a time period. The likelihood of use 
of BB was adjusted at the patient level for age, gender, ethnicity, comorbidities, and 
insurance. Change in hospital rate over time was then modeled as a function of hospital 
ownership, teaching status, urbanity, annual AMI volume, catheterization lab status, and 
the baseline rate. 
Results: We observed marked variability in the change in BB use over time at the hospi- 
tals with an absolute mean improvement of 8% (standard deviation (SD) 10.2%). After 
adjusting for patient characteristics and baseline rate, urban teaching hospitals 
(P=0.003) and higher volume (P=0.017) were found to be significantly associated with 
increased use of BB over time. Hospital ownership and catheterization lab status were 
not independently associated with change over time. 
Conclusion: Hospitals increased use of BB during the study period at different rates. We 
identified hospital ocation and volume as independent markers of larger increases in the 
use of BB. The heterogeneity in performance by hospital type may provide an opportunity 
to investigate successful strategies to accelerate improvement. 
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1168-163 Racial and Gender Differences in Refusal of Coronary 
Angiography 
Paul Heidenreich, Michael Shlipak, Jeffrey Geppert, Mark McClellan, VA Palo Alto Health 
Care System, Palo Alto, Califomia. 
Background. Racial and gender differences in the use of cardiovascular procedures are 
well documented. It is unclear to what extent patient refusal contributas to the difference 
in procedure use. Methods. To determine the effect of patient refusal on racial and gen- 
der differences in coronary angiography utilization we identified patients of age 65 or 
older admitted to hospitals performing coronary angiography from the Cooperative Car- 
diovascular Project Database, which includes nearly all Medicare beneficiaries admitted 
with an acute myocardial infarction (MI) from February 1994 through July 1995. In-hospi- 
tal use and refusal of coronary angiography adjusted for patient comorbidities, severity of 
infarction, hospital, physician, and socio-economic status. 
Results. Of 124,691 patients with acute MI 53,871 (43%) patients underwent angiogre- 
phy and 2,881 (2.4%) patients refused during hospitalization. Patients refusing angiogra- 
phy were more likely to be female (odds ratio 1.37, 95% confidence interval 1.23 - 1.53), 
black (odds ratio 1.26 versus whites, 1.02-1.56) and older (odds ratio 2.25 per 10 year 
increase, 2.05-2.43) when compared to patients that received angiogrephy. Angiography 
use was lower for blacks (odds ratio 0.78, 0.72-0.83) compared with whites, and for 
women (odds ratio 0.83, 0.80-0.86) compared with men. Increased refusal explained 6% 
(-3% to 15%) of the difference in angiography use between whites and blacks and 16% 
(10% to 22%) of the difference between males and females. Patients who refused were 
twice as likely to die during the year following MI (31% vs. 16%), but this mortality differ- 
ence disappeared after adjustment for patient-relatad variables. 
Conclusions. Elderly females and black patients are more likely to refuse angiography 
than are male and white patients. However, patient refusal is relatively uncommon and 
accounts for only a small fraction of the racial and gender differences in angiography uti- 
lization after MI. 
